These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 37400628)

  • 1. Regulatory T cells in autoimmune kidney diseases and transplantation.
    Mikami N; Sakaguchi S
    Nat Rev Nephrol; 2023 Sep; 19(9):544-557. PubMed ID: 37400628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treg Enhancing Therapies to Treat Autoimmune Diseases.
    Eggenhuizen PJ; Ng BH; Ooi JD
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases.
    Ohkura N; Sakaguchi S
    Cell Res; 2020 Jun; 30(6):465-474. PubMed ID: 32367041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities for Treg cell therapy for the treatment of human disease.
    Bluestone JA; McKenzie BS; Beilke J; Ramsdell F
    Front Immunol; 2023; 14():1166135. PubMed ID: 37153574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression.
    Mikami N; Kawakami R; Sakaguchi S
    Curr Opin Immunol; 2020 Dec; 67():36-41. PubMed ID: 32827951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
    Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
    Front Immunol; 2018; 9():2359. PubMed ID: 30369931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
    Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
    Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of FOXP3
    Mohr A; Atif M; Balderas R; Gorochov G; Miyara M
    Clin Exp Immunol; 2019 Jul; 197(1):24-35. PubMed ID: 30830965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Family of IL-10-secreting CD4+ T cells.
    Fujio K; Okamura T; Yamamoto K
    Adv Immunol; 2010; 105():99-130. PubMed ID: 20510731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bet v 1-specific T-cell receptor/forkhead box protein 3 transgenic T cells suppress Bet v 1-specific T-cell effector function in an activation-dependent manner.
    Schmetterer KG; Haiderer D; Leb-Reichl VM; Neunkirchner A; Jahn-Schmid B; Küng HJ; Schuch K; Steinberger P; Bohle B; Pickl WF
    J Allergy Clin Immunol; 2011 Jan; 127(1):238-45, 245.e1-3. PubMed ID: 21211658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives.
    Han Z; Ma K; Tao H; Liu H; Zhang J; Sai X; Li Y; Chi M; Nian Q; Song L; Liu C
    Front Immunol; 2022; 13():826732. PubMed ID: 35251009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges.
    Goswami TK; Singh M; Dhawan M; Mitra S; Emran TB; Rabaan AA; Mutair AA; Alawi ZA; Alhumaid S; Dhama K
    Hum Vaccin Immunother; 2022 Dec; 18(1):2035117. PubMed ID: 35240914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
    Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T
    Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREG-cell therapies for autoimmune rheumatic diseases.
    Miyara M; Ito Y; Sakaguchi S
    Nat Rev Rheumatol; 2014 Sep; 10(9):543-51. PubMed ID: 24980140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.
    Liu YH; Mölzer C; Makinen K; Kamoi K; Corbett CLC; Klaska IP; Reid DM; Wilson HM; Kuffová L; Cornall RJ; Forrester JV
    Front Immunol; 2020; 11():2071. PubMed ID: 33013877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treg Therapies Revisited: Tolerance Beyond Deletion.
    Pilat N; Sprent J
    Front Immunol; 2020; 11():622810. PubMed ID: 33633742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.